4
In 2022, ATscale disseminated evidence globally that demonstrates the powerful case for investing in AT. Providing just four assistive products - hearing aids, prostheses, eyeglasses, and wheelchairs - would result in a return on investment of 9:1. For a child in a low- or middle-income country, access to AT can later make a difference of US$100,000 in lifetime income.
ATscale is proud to have co-sponsored and promoted the first ever WHO and UNICEF Global Report on AT (GReAT) that demonstrates the vast unmet need for AT. ATscale will build on this evidence, and promote tools, guidance and expertise to assure quality service delivery.
In 2019-2021, ATscale, AT2030, and the Clinton Health Access Initiative conducted in-depth analyses to identify key barriers and promising AT market interventions. The findings from this work were published in five priority product narratives for wheelchairs, hearing aids, prostheses, eyeglasses, and digital AT. In 2022, ATscale used these to inform strategic investments and develop new projects and partnerships.
Front cover photo: Young girls in China
© China Disabled Persons’ Federation
Email: info@atscalepartnership.org
Website: atscalepartnership.org
Follow us on Twitter: @_Atscale